EQS-Adhoc: Evonik Industries AG: Preliminary figures for the second quarter of 2024 and adjustment of the outlook for the financial year 2024
|
EQS-Ad-hoc: Evonik Industries AG / Key word(s): Half Year Results/Change in Forecast Evonik Industries AG is already today publishing the following preliminary figures for the second quarter of 2024 and adjusting its outlook for the financial year 2024.
Based on preliminary, non-audited figures, Evonik expects an adjusted EBITDA* of €578 million in the second quarter of 2024 (Q2 2023: €450 million). The current market expectation is €531 million (Vara Research analyst consensus as of May 29, 2024). As there was still no broad-based macroeconomic recovery, company-specific factors in particular led to this positive development: In addition to continued strict cost discipline, good volume development in Specialty Additives, as well as a price recovery in Animal Nutrition and lower production costs were drivers of the sequential increase. Based on this development, Evonik is raising its outlook for adjusted EBITDA* as follows: The company now expects adjusted EBITDA* for the financial year 2024 to be between €1.9 billion and €2.2 billion (previously: €1.7 - €2.0 billion). Following a slight decline in the first quarter, sales in the second quarter were, based on preliminary figures, at just above €3.9 billion and thus around the level of the previous year (Q2 2023: €3.9 billion). Evonik Industries AG will publish final figures for the second quarter of 2024 on August 1, 2024, as planned. *Notes on key performance indicators (KPIs) can be found in the Financial Report of Evonik Industries AG starting on page 240. The Financial Report 2023 is available at: https://files.evonik.com/shared-files/evonik-financial-report-2023-9492.pdf Contact/person making the notification: Tim Lange Head of Investor Relations +49 201 177-3150 tim.lange@evonik.com End of Inside Information
15-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Evonik Industries AG |
| Rellinghauser Straße 1-11 | |
| 45128 Essen | |
| Germany | |
| Phone: | +49 (0) 201 177-01 |
| Fax: | +49 (0) 201 177-3475 |
| E-mail: | investor-relations@evonik.com |
| Internet: | www.evonik.com |
| ISIN: | DE000EVNK013 |
| WKN: | EVNK01 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange |
| EQS News ID: | 1946351 |
| End of Announcement | EQS News Service |
|
|
1946351 15-Jul-2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 13.108,00 | 12.199,00 | 14.955,00 | 18.488,00 | 15.267,00 | 15.157,00 | 15.500,00 | |
| EBITDA1,2 | 2.153,00 | 1.837,00 | 2.246,00 | 2.510,00 | 1.598,00 | 1.694,00 | 1.800,00 | |
| EBITDA-Margin3 | 16,43 | 15,06 | 15,02 | 13,58 | 10,47 | 11,18 | 11,61 | |
| EBIT1,4 | 1.080,00 | 819,00 | 1.173,00 | 942,00 | -243,00 | 577,00 | 680,00 | |
| EBIT-Margin5 | 8,24 | 6,71 | 7,84 | 5,10 | -1,59 | 3,81 | 4,39 | |
| Net Profit (Loss)1 | 2.127,00 | 479,00 | 767,00 | 555,00 | -452,00 | 240,00 | 285,00 | |
| Net-Margin6 | 16,23 | 3,93 | 5,13 | 3,00 | -2,96 | 1,58 | 1,84 | |
| Cashflow1,7 | 1.321,00 | 1.727,00 | 1.815,00 | 1.650,00 | 1.594,00 | 1.713,00 | 0,00 | |
| Earnings per share8 | 4,52 | 1,00 | 1,60 | 1,16 | -1,00 | 0,48 | 0,64 | |
| Dividend per share8 | 1,15 | 1,15 | 1,17 | 1,17 | 1,17 | 1,17 | 1,17 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Evonik Industries | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| EVNK01 | DE000EVNK013 | AG | 8.728,18 Mio € | 25.04.2013 | Halten | 9F39C2X7+QJ |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 15,87 | 19,67 | 0,81 | 13,62 | 1,03 | 5,10 | 0,58 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 1,17 | 1,17 | 1,17 | 6,25% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 28.05.2025 | 12.05.2025 | 01.08.2025 | 04.11.2025 | 05.03.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -4,22% | -1,90% | +11,95% | -2,90% | -41,83% |
